274
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Human HPRT1 gene and the Lesch–Nyhan disease: Substitution of alanine for glycine and inversely in the HGprt enzyme protein

, &
Pages 151-157 | Received 21 Apr 2016, Accepted 25 Aug 2016, Published online: 03 Jan 2017

References

  • Lesch, M.; Nyhan, W.L. A familial disorder of uric acid metabolism and central nervous system function. Am. J. Med. 1964, 36, 561–570.
  • Seegmiller, J.E.; Rosenbloom, F.M.; Kelley, W.N. Enzyme defect associated with a sex-linked human neurological disorder and excessive purine synthesis. Science 1967, 155, 1682–1684.
  • Patel, P.I.; Framson, P.E.; Caskey, C.T.; Chinault, A.C. Fine structure of the human hypoxanthine phosphoribosyltransferase gene. Mol. Cell. Biol. 1986, 6, 396–403.
  • Fu, R.; Ceballos-Picot, I.; Torres, R.J.; Larovere, L.E.; Yamada, Y.; Nguyen, K.V.; Hegde, M.; Visser, J.E.; Schretlen, D.J.; Nyhan, W.L.; Puig, J.G.; O'Neill, P.J.; Jinnah, H.A. For the Lesch–Nyhan disease international study group. Genotype-phenotype correlations in neurogenetics: Lesch–Nyhan disease as a model disorder. Brain 2014, 137, 1282–1303.
  • Nguyen, K.V.; Naviaux, R.K.; Paik, K.K.; Nyhan, W.L. Novel mutations in the human HPRT gene. Nucleosides Nucleotides Nucleic Acids 2011, 30, 440–445.
  • Shi, W.; Li, C.M.; Tyler, P.C.; Furneaux, R.H.; Grubmeyer, C.; Schramm, V.L.; Almo, S.C. The 2.0 A° structure of human hypoxanthine-guanine phosphoribosyl-transferase in complex with a transition-state analog inhibitor. Nat. Struct. Biol. 1999, 6, 588–593.
  • Duan, J.; Nilsson, L.; Lambert, B. Structure and functional analysis of mutations at the human hypoxanthine phosphoribosyltransferase (HPRT1) locus. Hum. Mutat. 2004, 23, 599–611.
  • Doig, A.J.; Baldwin, R.L. N-and C-capping preferences for all 20 amino acids in α-helical peptides. Prot. Sci. 1995, 4, 1325–1336.
  • Serrano, L.; Sancho, J.; Hirshberg, M.; Fersht, A.R. α-Helix stability in proteins I. Empirical correlations concerning substitution of side-chains at the N and C-caps and the replacement of alanine by glycine or serine at solvent-exposed surfaces. J. Mol. Biol. 1992, 227, 544–559.
  • Trigueros, G.M.; Torres, R.J. From genotype to phenotype; clinical variability in Lesch–Nyhan disease. The role of epigenetics. Rev. Clin. Esp. 2014, 214, 461–465.
  • Nguyen, K.V. Epigenetic regulation in amyloid precursor protein and the Lesch–Nyhan syndrome. Biochem. Biophys. Res. Commun. 2014, 446, 1091–1095.
  • Nguyen, K.V. The human β-amyloid precursor protein: biomolecular and epigenetic aspects. Biomol. Concepts 2015, 6, 11–32.
  • Nguyen, K.V. Epigenetic regulation in amyloid precursor protein with genomic rearrangements and the Lesch–Nyhan syndrome. Nucleosides Nucleotides Nucleic Acids 2015, 34, 674–690.
  • Kang, T.H.; Friedmann, T. Alzheimer's disease shares gene expression aberrations with purinergicdysregulation of HPRT deficiency (Lesch–Nyhan disease). Neurosci. Lett. 2015, 590, 35–39.
  • Knapp, D.J.; Breese, G.R. The use of perinatal 6-hydroxydopamine to produce a rodent model of Lesch–Nyhan disease. Curr. Top. Behav. Neurosci. 2016, 29, 265–277.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.